EP Patent

EP2431033A1 — Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation

Assigned to Sanofi SA · Expires 2012-03-21 · 14y expired

What this patent protects

Use of dronedarone or pharmaceutically acceptable salts thereof, for the preparation of a medicament for the prevention of cardiovascular hospitalization or of mortality in patients with lone atrial fibrillation.

USPTO Abstract

Use of dronedarone or pharmaceutically acceptable salts thereof, for the preparation of a medicament for the prevention of cardiovascular hospitalization or of mortality in patients with lone atrial fibrillation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2431033A1
Jurisdiction
EP
Classification
—
Expires
2012-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.